Case Control Study
Copyright ©The Author(s) 2019.
World J Clin Cases. Jan 26, 2019; 7(2): 130-136
Published online Jan 26, 2019. doi: 10.12998/wjcc.v7.i2.130
Table 1 Patient characteristics
VariablenFrequency [n (%), or mean ± SD]Median (range)
Age930.00 ± 15.7529.00 (12.00-60.00)
Gender (male/female)94 (44.4)/5 (55.6)
Hepatitis B virus90 (0)
Hepatitis C virus90 (0)
Alcohol abuse90 (0)
Vascular obstruction
IVC obstruction92 (22.2)
RHV obstruction98 (88.9)
MHV obstruction97 (77.8)
LHV obstruction99 (100.0)
All HVs obstruction96 (66.7)
Portal vein thrombosis90 (0)
Clinical presentations and signs
Hepatic encephalopathy before TIPS90 (0)
Gastrointestinal bleeding93 (33.3)
Abdominal pain92 (22.2)
Abdominal distension97 (77.8)
Abdominal varices91 (11.1)
Limb swelling91 (11.1)
Pigmentation91 (11.1)
Limb ulcer91 (11.1)
CT signs
Hydrothorax on CT93 (33.3)
Ascites on CT94 (44.4)
Splenomegaly on CT98 (88.9)
Hepatic patchy enhancement on CT97 (77.8)
Gastroesophageal varices on CT97 (77.8)
Paraesophageal varices on CT91 (11.1)
Laboratory tests
Hemoglobin (g/L)9122.67 ± 34.81127.00 (82.00-171.00)
White blood cell (109/L)96.86 ± 2.856.67 (2.99-12.48)
Platelet count (109/L)9122.22 ± 69.32109.00 (42.00-270.00)
Alanine aminotransferase (U/L)929.22 ± 17.5623.00 (13.00-71.00)
Aspartate aminotransferase (U/L)947.22 ± 20.9739.00 (18.00-71.00)
Alkaline phosphatase (U/L)9178.33 ± 69.20148.00 (96.00-288.00)
Gamma glutamyl transferase (U/L)993.44 ± 42.2184.00 (19.00-161.00)
Total bilirubin (mmol/L)986.98 ± 91.8142.80 (18.90-262.40)
Direct bilirubin (mmol/L)957.71 ± 68.4217.30 (6.20-180.00)
Albumin (g/L)936.19 ± 7.0839.60 (22.20-44.10)
Prothrombin time (s)955.67 ± 15.3356.00 (25.00-78.00)
International normalized ratio91.48 ± 0.431.37 (1.12-2.55)
Serum creatinine (mmol/L)951.00 ± 14.6550.00 (29.00-76.00)
Blood urea nitrogen (mmol/L)95.06 ± 1.515.15 (2.94-8.27)
Sodium (mmol/L)9134.78 ± 8.56138.00 (120.00-143.00)
Potassium (mmol/L)94.33 ± 0.644.17 (3.77-5.77)
Collagen proportionate area923.44 ± 13.8823.07 (0-40.20)
Shunt dysfunction after TIPS92 (22.2)
Hepatic encephalopathy after TIPS91 (11.1)